Investors

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that notice of the Company’s 2022 adjourned annual general meeting (“2022 AGM”) has been sent to shareholders today.

The 2022 AGM will be held at Regus, Churchill Court 3, Crawley, RH10 9LU on 15 March 2024 at 13:00.

Certain of the original resolutions have been withdrawn, these resolutions related to the Director’s authority to allot new ordinary shares in the Company and the disapplication of pre-emption rights.

A copy of the notice of the 2022 AGM, along with the form of proxy, will be shortly available from the Company’s website http://truspine.org/

Enquiries:

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.